What is HC Wainwright’s Forecast for OVID FY2026 Earnings?
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Research analysts at HC Wainwright issued their FY2026 EPS estimates for Ovid Therapeutics in a research report issued to clients and investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings per share of ($0.60) for the year. HC Wainwright […]
